相关实验视频
Updated: Jul 21, 2025

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.2K
意识到粉样聚合是疾病发病的常见原因
1Department of Chemistry, Indrashil University, Kadi, Mehsana 382740, Gujarat, India.
Life (Basel, Switzerland)
|July 29, 2023
概括
以前认为仅以蛋白质为基础的粉样蛋白,可以从代谢物中形成,导致各种疾病. 了解这些有毒组合为共同的治疗策略提供了潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 传统上,粉样蛋白涉及蛋白质/聚 (例如,阿尔茨海默氏症中的Aβ42,性疾病中的蛋白).
- 最近的发现揭示了非蛋白质代谢物 (氨基酸,脂质等). 它们也形成类似粉样蛋白的有毒组合.
- 这些代谢物组合涉及到代谢障碍,如基尿症和高氏病.
研究的目的:
- 在各种疾病中提供粉样样结构形成的全面概述.
- 阐明细胞外粉样蛋白的结构,形成,传播和传播.
- 提高人们对粉样蛋白在疾病发病过程中的作用的认识,并探索共同的治疗点.
主要方法:
- 关于粉样蛋白形成和疾病的研究的综合文献综述.
- 从蛋白质和代谢物中形成粉样蛋白聚合的基础分子机制的分析.
- 关于粉样蛋白在神经退行性,代谢性和其他疾病中的影响信息的综合.
主要成果:
- 粉样样结构的形成是各种综合征中常见的致病机制,不仅限于蛋白质.
- 代谢物衍生的粉样化合物组合在代谢的先天性错误的病理生理学中起着重要的作用.
- 细胞外粉样蛋白在与疾病相关的结构,形成和传播方面具有共同的特征.
结论:
- 粉样蛋白形成是一种统一的分子机制,是各种疾病的基础.
- 了解代谢物衍生的粉样蛋白对于理解疾病的发病过程至关重要.
- 开发通用粉样蛋白抑制剂为新的治疗策略提供了一个有希望的途径.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Alzheimer's Disease: Overview
522
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
522

